(Q36238729)

English

Yellow fever vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

Yellow fever vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

yellow fever virus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thomas P. Monath

1

object named as

Thomas P Monath

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Expert Review of Vaccines

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

553-574

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Yellow fever: a decade of reemergence

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

The use of yellow fever virus modified by in vitro cultivation for human immunization

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Contaminant viruses in two live virus vaccines produced in chick cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Yellow fever vaccination, avian leukosis virus, and cancer risk in man.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Adventitious viral genomes in vaccines but not in vaccinees

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Isolation of Plaque Variants Differing in Virulence from the 17D Strain of Yellow Fever Virus

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Structure of the dengue virus envelope protein after membrane fusion

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Molecular characterization of a hamster viscerotropic strain of yellow fever virus

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Human skin Langerhans cells are targets of dengue virus infection

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Concurrent and consecutive infection and immunisation with yellow fever and UGMP-359 viruses

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Protective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell Responses

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Phylogenetic and Evolutionary Relationships among Yellow Fever Virus Isolates in Africa

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Studies on yellow fever vaccine. III--Dose response in volunteers

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

PERSISTENCE OF YELLOW FEVER VIRUS IN THE BRAINS OF MONKEYS IMMUNIZED BY CEREBRAL INOCULATION.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

THE USE OF MICE IN TESTS OF IMMUNITY AGAINST YELLOW FEVER

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

History of thymoma and yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

What is Good's syndrome? Immunological abnormalities in patients with thymoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Severe T- and B-cell immune deficiency associated with malignant thymoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Effects of Anti-thymocyte Serum on 17-D Yellow Fever Infection in Adult Mice

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Anaphylaxis from yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Yellow fever vaccination and pregnancy: a four-year prospective study

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Congenital yellow fever virus infection after immunization in pregnancy

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

A chimeric live attenuated vaccine against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Prevention of yellow fever in persons traveling to the tropics

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.553

21 January 2018

Research on dengue during World War II

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4269/AJTMH.1952.1.30

Identifiers

10.1586/14760584.4.4.553

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36238729&oldid=1965513963"